KCKantinan Chuensirikulchai

Kantinan Chuensirikulchai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kantinan Chuensirikulchai has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Zika virus vaccine with E protein fusion loop mutations protects via CD8+ T cells

    by Kantinan Chuensirikulchai, Qin Hui Li, Hsueh-Han Lu, Julia Timis, Manuel Montano, Luke Eder, Pradip Bhandari, Dawid Zyla, Maximilian Bunz, Henry Madany, et al.

  • Open Access

    Immune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 Vaccine

    by Witida Laopajon, Athavudh Deesomchok, Warawut Chaiwong, Nuchjira Takheaw, Supansa Pata, Pilaiporn Duangjit, Juthamas Inchai, Chaicharn Pothirat, Chaiwat Bumroongkit, Theerakorn Theerakittikul, et al.

    Laopajon W, et al. Infect Chemother. 2025 Apr;57:e25. https://doi.org/10.3947/ic.2024.0145

  • Identification of different functions of CD8+ T cell subpopulations by a novel monoclonal antibody

    by Kantinan Chuensirikulchai, Supansa Pata, Witida Laopajon, Nuchjira Takheaw, Kamonporn Kotemul, Kanyaruck Jindaphun, Saichit Khummuang, Watchara Kasinrerk

    The explicit identification of CD8+ T cell subpopulation is important for deciphering the role of CD8+ T cells for protecting our body against invading pathogens and cancer. Our generated monoclonal antibody (mAb), named FE‐1H10, recognized two novel subpopulations of peripheral blood CD8+ T cells, FE‐1H10+ and FE‐1H10− CD8+ T cells. The molecule recognized by mAb FE‐1H10 (FE‐1H10 molecules) had a higher distribution on effector memory CD8+ T cell subsets. The functions of FE‐1H10− and FE‐1H10+ CD8+ T cells were investigated. T cell proliferation assays revealed that FE‐1H10− CD8+ T cells exhibited a higher proliferation rate than FE‐1H10+ CD8+ T cells, whereas FE‐1H10+ CD8+ T cells produced higher levels of IFN‐γ and TNF‐α than FE‐1H10− CD8+ T cells. In T cell cytotoxicity assays, FE‐1H10+ CD8+ T cells were able to kill target cells better than FE‐1H10− CD8+ T cells. RNA‐sequencing analysis confirmed that these subpopulations were distinct: FE‐1H10+ CD8+ T cells have higher expression of genes involved in effector functions (IFNG, TNF, GZMB, PRF1, GNLY, FASL, CX3CR1) while FE‐1H10− CD8+ T cells have greater expression of genes related to memory CD8+ T cell populations (CCR7, SELL, TCF7, CD40LG). The results suggested that mAb FE‐1H10 identifies two novel distinctive CD8+ T cell subpopulations. The FE‐1H10+ CD8+ T cells carried a superior functionality in response to tumour cells. The uncover of these novel CD8+ T cell subpopulations may be the basis knowledge of an optional immunotherapy for the selection of potential CD8+ T cells in cancer treatment.


  • Open Access

    Characterization and functional analysis of novel circulating NK cell sub-populations

    by Saichit Khummuang, Kantinan Chuensirikulchai, Supansa Pata, Witida Laopajon, Nuttapol Chruewkamlow, Kodchakorn Mahasongkram, Nobuo Sugiura, Hideto Watanabe, Hiroaki Tateno, Ludthawun Kamuthachad, et al.

    Natural killer (NK) cells are innate lymphoid cells having potent cytolytic function that provide host defense against microbial infections and tumors. Using our generated monoclonal antibody (mAb), named FE-1H10, new NK cell sub-populations in peripheral blood were identified. The molecules recognized by mAb FE-1H10 were expressed on a sub-population of CD3−CD56dim NK cells. The epitope recognized by mAb FE-1H10 was demonstrated to be N-glycan and proven to be different from CD57. Upon K562 stimulation, the CD56dimFE-1H10+ NK cell sub-population exhibited significantly lower cytolytic function with low ability to degranulate and release cytolytic granules compared to the CD56dimFE-1H10− NK cell sub-population. Moreover, the CD56dimFE-1H10+ NK cells produced less IFN-γ and TNF-α than the CD56dimFE-1H10− NK cells. We demonstrated here that mAb FE-1H10 could identify two sub-populations of circulating CD56dim NK cells with different functions. Our discovery of new sub-populations of NK cells improves our understanding of NK cell biology and may lead to the development of new approaches for NK cell therapy.